Influence of coronary heart disease on morbidity and mortality after lower extremity revascularization surgery: A population-based study in Olmsted County, Minnesota (1970–1987)  by Farkouh, Michael E. et al.
with peripheral vascular disease, 
ut at&t on long4erm outcome 
ry. However, lonfpterm outcome is 
examined the entire community medical records 
of Blmsted County, Minne~~, 
peripheral ertey bypass surgery between 1970 an 
death, myocardisl i~~~~ti~~ or woke be 
Occlusive vascular diseasc affecting lower extremity vascular 
beds leads to ischemia of the legs and feet, manifesting as
clinical conditions ranging from intermittent claudication to 
gangrene. Since the introduction f bypass grafting for both 
aortoiliac and femoropopliteal occlusive disease in the 195Os, 
lower extremity revasculurization procedures have become 
widely performed throughout the world. According to the Joint 
Committee on Vascular Surgery Manpower (l), there are 
102,000 peripheral rtery revascularization pr cedures carried 
out in the IJnited States annually. One study (2) has hown that 
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019% by the American College of Cardiology 
the annual rate of peripheral rtery bypass surgery doubled 
from 1979 to 1989. 
The association between coronary heart disease and periph- 
eral vascular disease iswell documented. It is estimated that 
90% of patients with peripheral rtery disease have atheroscle- 
rosis involving other vascular sys!ems (3). In some studies, up 
to 50% of patients with peripheral rtery disease have severe 
coronary artery disease (4). It is increasingly c ear that coro- 
nary heart disease isthe most common cause of early and late 
postoperative d ath in patients undergoing peripheral rtery 
bypass surgery (5,6). Two previous Olmsted County, Minne- 
sota, population-based stu ies (7,8) documented the increased 
cardiac mortality and morbidity inpatients with overt coronary 
heart disease who underwent abdominal ortic aneurysm 
repair or carotid endarterectomy. 
It is important to evaluate the cardiovascular risk factors 
that influence both early and late mortality in patients with 
peripheral rtery disease. The five risk factors most strougly 
associated with postoperative mortality include histq of 
previous myocardial nfarction or stroke; presence ofc’ )ngca- 
tive heart failure and arrhythmias; nd an abnormal e ectro- 
cardiogram (9). In patients with a left ventricular ejection 
fraction 535%, the 30-day postoperative mortality rate for 
073%1097/94/$7.00 
f patients withaccess ao consis- 
ient medical records (11). This study was reviewed 
Olmsted County residents who o~de~ent an initial, elective 
peripheral artery revascularization procedure for occlusive 
atherosclerotic disease between the years 1970 and 1987 were 
identified. Peripheral vascular surgery in this context was 
identified as aortoiliac or aortofemora~ grafting or fe 
liteal or infrapopliteal revascularization. Patients u 
surgery for abdominal ane mal disease were excluded, as 
were pdtLnts ~~dergo~~g e gency surgery for acute arterial 
occlusion. 
&a e~~~ect~o~. The data ab cted from the complete 
ed County medical records yo Clinic, Olmsted Med- 
ical Group and Olmsted Community Hospital) for the cohort 
included general demographic data, type and indication for 
surgery and risk factors for atherosclerc;,is, Historical data 
pertaining to coronary heart disease, including investigations 
before operation, were recorded. Patients were classified by 
the absence (Group 1) or presence (Group 2) of overt coro- 
nary artery disease. Overt coronary disease was defined by 
history of myocardial infarction documented by cardiac en- 
zyme measurement or electrocardiography, a history of angina 
pectoris or a positive noninvasive functiotlal study. The end 
points were death and cardiac events. Significant cardiac 
events were defined as cardiac death, myocardial infarction, 
pulmonary edema, ventricular dysrhythmias requiring therapy, 
coronary artery bypass urgery or coronary angioplasty. Vital 
status and cause of death were recorded. Uniformity of clinical 
Group 1’ Group 2: 
No. of Pts No. of Pts 
(n = 106) % (n = 60) 4 p “&,c$ 
Male gender 61 58 40 63 0.25 
Diabetes mektus 18 17 21 35 MH 
Hypertension 54 52 32 51 0.86 
Smoking 96 91 45 39 0.02 
History of cancer 13 13 8 13 0.84 
Hislory of CHF 4 4 15 25 < 0.w1 
Family hktory 24 26 26 33 0.43 
Median age (yr) 63.1 68.8 o.iog 
Median cholesterol (mg/ddl) 237 237 a.239 
- 
“NO evije~lcc of coronary heart disease. ‘IOve rtonwascularized coronary 
heart disease. $Chi-square test. #KildL~SMM tcsl. C F = congestive heart failure: 
I% c pahms. 
sed across other studies of Blmsted 
aintained. 
patients were followed IJ 
1, 1991 for death or cardiac and ral vascular events 
Information was obtained throug of the entire com- 
munity medical record and supplemented bytelephone inquiry 
sis. Standard descriptive statistics were 
quare and ~o~~ararnet~~c methods, as 
re subjects with and witbout coronary 
e of lower extrerrity revascularizatiom 
surgery. Univ,riable survival of rhese two groups was com- 
pared using the log rank test. The Kaplan-Meier product limit 
method was used to estimate the probability of surviving or 
surviving free of a cardiac event after lower extremity revas- 
cularization surgery as a function of time (12). Expected 
survival rates are based on the 1980 mortality rates of the 
Minnesota white population taking into account he age and 
gender distribution of the lower extremity revascularization 
surgery cohort. Multivariable analysis using the Cox propor- 
tional hazards model was performed to evaluate predictor5 of
death and cardiac events after lower extremity revasculariza- 
tion surgery (13). Statistical significance was inferred at p 5 
0.05, and all reported p values are two-tailed. 
aselirae c~~a~acte~~st~es~ Of h  173 Olmsted County resi- 
dents in the cohort, 106 had no evidence of coronary heart 
disease at the time of peripheral revascularization procedure 
(Group 1). Sixty patients had evidence of overt, nonrevascu- 
larized coronary ai;ery discasa (Group a), and seven had 
previous coronary artery bypass urgery (Group 3). Because of 
the small number of patients in Group 3, intergroup compar- 
isons were restricted lo Groups 1 and 2 (Table 1). The mean 
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2 Perioperatk Morbidity and Mortality Rates at 30 Days 
g Olmted County Residents who Underwent Lower 
Extremity Revaseula&ation Surgery for Atherosclerotic Disease 
Between 1970 and 1987 - 
Group 1 Group 2 
P 
No. of Fts % No. of Prs % VahK’ 
Toral group 106 IOU 60 1tJO 
Myxardial infatiion I I 1 2 1.00 
Ventricular tachycardiz 0 0 0 0 - 
Cardiac arrest 0 0 1 3 0.13 
Pulmonary edema 0 0 1 z 0.36 
PTCA or CABG 0 0 0 u - 
‘Pm&at khemic attsek 0 0 0 0 - 
Stroke I 1 0 I) 1.M 
8th I I 3 5 0. I4 
Patients with 2 1 event 3 3 3 5 0.6-l 
__s 
age was 64 years, and tkc majority ofpaticnls were malt (62%) 
and had a history of st~o~iii~ (87%). The median serum 
cholesterol level was 236 mgIdl. There was a signi~cantly 
greater proportion of patients with diabetes (35% vs. 17%. 
p = 0.01) or a history of congestive h art failure (25% vs. 4%, 
ith overt coronary heart disease. 
and indications. Fifty percent of 
rization surgical procedures were 
performed for intermittent claudication, 17% for rest pain, 
21% for nonhealing ulcers or nonresolving i fection, or both, 
and 8% for lower extremity gangrene formation. The primary 
indication for operation could not be ascertained in 4% of 
patients. 
When the type of lower Extremity revar~ularization surgery 
performed was considered, the cohort was divided into those 
with aortoiliac oraortofemoral bypass urgery (Group 1, n = 
100) and those with more distal revasculariaation (Group 2, 
surgery are displayed in Table 2. The overall case fatality rate 
was 2%. There were no statistically significant +;fferences 
between Groups 1 and 2 with respect to individual cardiac or 
neurologic event rates at 30 dqs. 
The probability of having any perioprative complication 
was greater for those with overt coronary heart disease (5% vs. 
3%). This difference, however, was not statistically significant 
(p = 0.67). 
There was no significant difference in the 30-day morbidity 
and mortality rates between thase patients with aortoiliac or 
~Wokmoml bypass surgery (Group 1) and those undergoing 
femoropopliteal or more distal surgery (Group 2) (Table 3). 
-term survival. At the end of the follow-up eriod, 99 
(57%) of 173 subjects inthe study cohort had died. Of the 74 
(43%) still alive a: last fellow-up. the median follow-up eriod 
W* 6.9 years, with 21 patients having been under observation 
for at least 10 years. of the deaths, 24 (49%) of 49 in Group 1 
‘M&? 3. Perioperative Morbidity and Mortality Rates at 30 Days 
Between Patients With Aortoiliac or Aortofemoral 
Compared With More Distal Lower F.xtremity 
Aortoiliac or ~e~~r~~~~~~~~ea~ 
Aortofemoral IBypass or :&re 
BypilSS Disrat Surgerv 
No. of Pts No. of Pts 
(rl = 73) B “aPue” 
klyocardial hrfarcnibn 1 2 0 0 0.51 
Ventricular tachycaedia 0 0 0 0 - 
Cardiac axwt 1 1 1 I i .oo 
Pulmonsty edemu (1 0 I I 0.42 
CABG or PTCA 0 0 0 c9 - 
Tnnsicnt ischcmic attack I! ar 0 l9 - 
Stroke 0 0 I 1 W! 
Dl%ltll 3 3 I I 0.6.1 
Ppticrlts with r I SWIII 4 4 ? 3 I .Nl 
“Fisher cxircl IC% Al~hrc~lali~~~~s IS in ‘I‘;lblCs I ik!Id 2. 
and 20 (45%) of 44 ia Group 2 were of a CilIXklC ~~ri~~~ (p = 
0.73); the number of deaths fram stroke were similar between 
the two groups (6% vs. 7%, p = 0.83). 
The overall Kaplau-Meier stimated provability of survival 
at 10 years uas 39% si~~~fica~tly poorer than the expected rate 
of 71% busies as a refe 
f 
r-adjusted 1980 
) (Fig. I). 
1 patients (without overt coronary artery dis- 
n-Meier estimated 5 and IO-year sunival 
and 51% respectively (expected IO-year 
surviva! rate was 73%, p < 0. Among Group 2 patients 
rt coronav artery se), the 5- and IO-year 
eier survival rates after surgery were 54% and 24%. 
respectively (expected IO-year survival rate was 66%, p < 
O.OOOl) (Fig. 2). Patients with overt coronary beart disease 
(Group 2) bad significantly lower survival rates than those 
without coronas heart disease (p < 0 
Patients undergoing aortoiliac or ao 
more likely to be alive at 10 years after lower extremity 
revascularization surgery than were patients undergoing femo- 
ropopliteal surgery (47% vs. , p = 0.001) (Fig. 3). 
vascMlar~ve~~ &la In terms 
of the probability of cardiac event-free survival, a marked 
disparity between Groups 1 and 2 was observed (Fig. 4). The 
cumulative incidence of a significant cardiac event (cardiac 
death, myocardial nfarction, cardiac arrest, coronary revascu- 
larization, pulmonary edema or ventricular tachycardia) at 5 
years after lower extremity revascularization surgery was 50% 
for Group 2 but only 28% for Group 1 (p = 0.003). 
Among the isolated event rates hown in Table 4, 15% of 
Group 2 patients underwent coronary revascularization proce- 
dures postoperatively compared with 8% of Group 1 patients 
(p = 0.05; patients with previous bypass surgery at baseline 
were xcluded). Moreover, a significantly greater proportion of
patients in Group 2 experienced an episode of pulmonary 
edema during the follow-up eriod (33% vs. 13%, p= 0.0005). 
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eier life-table analysis comparing 
a0 between residents of ~~~ste~ 
innesota, who undereat llower extremity 
revasc~~ar~ati~~ surgery between 19 
an age- and ge~de~~a~j~ste~ 1980 
cohort. 
survival was not di 
tional ba~rds m 
an-Meier life-table analysis comparing probability of 
n residents of Olmsted County, Minnesota, who under- 
went lower extremity revascularization surgery between 1970 and 1987 
with an age- and gender-adjusted 1980 Minnesota white cohort. U 
, Group 1 = patients with no history of coronary heart disease; 
net, Group 2 = patients with overt coronary heart disease; 
and, Group 1 versus Group 2. 
20 Group 1 
0 
statistically sig~~i~ca~~t predictors of survival (p .: 0.05). For 
c evenls, the presence of overt coronary 
diabetes was ~n~~e~~e~de~t~y associateci w th 
atysis. In the muhivaria 
nary heart disease (hazar 
confidence interval [Cl] 1.38 to 3.08), diabetes (hazard ratio 
2.02, 95% Cl 1.26 to 3.19) and age (hazard ratio for IO-year 
diac events. 
associated with subsequent car- 
s aby oft yQ A population-based approach 
to the investigation f outcomes after surgical procedures has 
advantages. Referral bias is minimized, as is regional variation 
in practice patterns. This population-based cohort analysis 
evaluated all patients in Olmsted County who underwent lo 
extremity revascularization for occlusive arterial disease. 
tients undergoing operation primarily for abdominal neurys- 
mal disease were excluded and form the basis of anc!her eport 
(7). With this design, complete fs&lov+up through January 1, 
1991 was possible. 
The major @dings of this study are that patients who 
urdergo peripheral revascularization surgery experience x- 
tremely high rates of cardiac omplications during longitudinal 
ervation and that long-term survival is significantly poorer 
that of an age- and gender-matched populatjo~. The 
subgroup of patients with overt coronary artery drsease are at 
highest risk. 
With regard to perioperative (up to 30 days postoperative) 
complications, patients with overt coronary artery disease 
experienced a perioperative myocardial infarction rate 01 2%, 
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which was not clinically or statistically difkrent from those 
patients without overt coronary disease. This ~~k~din~ is some- 
what surprising given the results of the lo 
and the previously reported (7) experien 
aortic aneurysmorraphy. The relatively low incidence of perio- 
perative myocardial infarction observed is similar to that seen 
after carotid endarterectomy (8). The observed higher rates of 
perioperative cardiac arrest (3% vs. 0%) and death rates (5% 
vs. 1%) among patients with overt coronary artery disease did 
not reach statistical significance because of the low power of 
our researctr design in detecting differences in perioperativc 
morbidity and mortality given the overall low occurrence of 
untoward clinical events in this high volume surgical setting. 
require operative management 
for severe peripheral vascular disease. These patients may or 
may not have clinical evidence of coronary artery d 
has been advocated recently that such patients un 
stratification with functional cardiac testing and, presumably, 
F&m 3. Kaplan-Meier life-table analysis com- 
paring probability of survival between patients 
who underwent aortoiliac or aorlofe~o~a~ by- 
pass surgery (Group A) and those who under- 
went more distal surgery (grout 
undergo coronary angiogra 
cularization if the f~~ct~o~ 
based data do not slrppor t the co~c~~si~~ t 
bypass surgery or coron 
lower the risks of perio 
~ri~bera~ v~c~~ar surge 
that our pati~~ts were c 
observed 4% absolute di 
not reach statistical s~g~i~cance, this pr 
contention t&sat coron 
tion is indicated ~rimari~y reduce the risk of a subsequent 
operation. Indeed, such a stioa is appropriately addressed 
only with a prospective, randomized trial. 
Long ~rrm. The current data, as weI1 as our previously 
published popu~ation~based reports (7,8), lend strong support 
to the concept that careful longitudinal observation of patients 
Figure 4. Kaplan-Meier estimate of cardiac 
event-free survival between patients with overt 
coroaary heart disease (6roup 2) and those 
without coronary heart disease (Group 1). 
I I 
0 2 4 
ii A 
10 
Gmwl,n=S8 85 77 71 08 40 37 22 15 
-@P2.n== is 37 27 23 16 15 11 lo 7 6 
Yeats after surgery 
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GWJp 1 Groulp 2 
No. of No. of P 
Pts c; Pts “i Value” 
Cardiac arrest 10 9 9 15 0.124 
Myocardial iilfarction 31 29 17 2s 0.303 
CABG or PTCA R 8 Y I5 0.047 
Pulmonary edema I4 13 40 33 0.0005 
Ventricolar tachycardia 3 3 4 7 0.073 
Patients with Sl event 42 40 38 63 o.ooo3 
*Log rank test. Abbreviations as in Tables I and 2. 
heral vascular disease is indicated. ‘These 
intermittent s~a~d~catio~ led toa doubling of the mortality rate 
and a significant reduction in life 
ence of diabetes mellitus and fe iteal disease are 
arkew of patients at big 
nature of vascular disease. In *his study, the lower survival rates 
for the more distal revascularization group (Group 2) can 
probably be explained by the resemce of more diabetic 
lhall drill the aortoiliac or aortofemora] 
alad treatment. It is reasonable to s 
overt coronary artery 
disease were also at considerable risk for sjg~j~ca~t la e 
rable evidence xists 0% a signi 
th ~er~~hera~ artery disease w 
clinical coronary artery disease will anifest myocardial isch- 
emia on noninvasive t sting (17). Mertzer et al. (3) sh 
-14% of patients with peripheral artery disease w 
clinical indication ofcoro~a~ heart disease were found to have 
angiographic evidence for severe, surgically correcta 
nary artery disease. ~o~~~vas~ve cardiac assessment with vig- 
orous stress testing may identify those asymptomatic patients 
Table 5. Univariilble and Multivariable Cox Proportb:al Hazards ode1 for Death and Cardiac Events Among Olmsted County 
Who Underwent Lower Exretnity Revascularization Surgccry for Athcrosclcrotic Disease Between 1970 and 1987, VW a IWow-Up Period lo 
January 1, 1991” 
Qra& Cardiac Bents 
Univariable Multivariable Univarkble Multivariable 
Hazard Hazard Hazard Nazard 
Variable Ratio p Value Ratio p Value Ratio p Value Ratio p Value 
Age ( IO-yr difference) LHO < 0.0001 1.66 < 0.0001 1.14 0.23 1.81 0.016 
(1.47-2.20) (1.34-2.05) (0.92-1.42) (1.12-2.93) 
Diabeks (1 = 0 = no) yes, 2.91 < 0.0001 2.02 0.0025 2.12 0.004 2.38 0.001 
(1.88-4.52) (1.2&3.19) (1.26-3.56) (1.40-4.04) 
Coronary heart disease (1 = yes, 0 = no) 2.08 0.0003 2.07 0.0004 2.12 0.002 
(1.40-3.10) (1.38-3.08) (1.33-3.38) 
Hypertension (1 = yes, 0 = no) 1.49 0.054 0.74 
(0.99-2.24) (0.46-1.18) 0.2 
Gender (1 = male, 0 = female) 0.86 0.47 1.39 
(0.57-1.30) (0.83-2.33) 0.2 
Family hislory of coronary heart disease 0.92 0.72 1.35 
(0.57-1.47) (0.X1-2.23) 0.2 
Serum cholesterol (50 mddl difference) 1 .oo 0.97 l.Ou 
(0.99-1.01) (0.997-1 .lO) 0.4 
Hislory of smoking 0.26 < O.OUOI 0.55 
(0.15-0.45) (0.27-1.13) 0.1 
‘95% confidence intervals are shown in parentheses. 
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at risk for a subsequent cardiac event, including death. In ar 
study spanning the past wo decades, most of these operations 
preceded the widespread use of preoperative functional car- 
diac assessment. I  fact, onily 30% of our patients had at least 
one preoperative noninvasive cardiac assessment. 
There are a number of important limi- 
interpreting the results of population- 
based studies such as ours. Significant advances have occurred 
in the medical nd surgical management (both from a coronary 
and peripheral vascular standpoint) of such patients over the 
ection zlud follow-up were 
s avoided. Our data strictly 
their dam was not a~~~~~ eno 
to avoid am 
s. All patients undergoing peripheral v~Mlar 
~~~~i~~tion are at high risk of future cardiac events, both 
fatal and nonfatal. The subgroup ofpatients with overt coro- 
disease s’.ould be considered athighest risk and 
ffered appropriate management op ions in an effort 
iac morbidity and mortality. 
We that& C]nthit\ Crowson for computer pr~rammin$ and statistical anriysis. 
This work was made possible rhrough the support of the Mayo Internal Medicine 
Residency Program. 
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